NCT07653594

TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)

Not Yet Recruiting
NAAges 50–80InterventionalSupportive care
Case Comprehensive Cancer Center
~20 participants
Updated 2026-06-17 on ClinicalTrials.gov
What's tested:Music-assisted relaxation and imagery (MARI)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of participants whose phlebotomy was collected prior to surgery
Measured over Within 2 weeks prior to surgery
+2 more outcomes measured
Surgery
Stomach Cancer
Pancreas Cancer
Bile Duct Cancer
Liver Cancer
Peritoneal Cancer
1 sites across 1 states
Ohio1
  • Samuel N Rodgers-Melnick, PhD, MPH · PRINCIPAL_INVESTIGATOR · Case Comprehensive Cancer Center, University Hospitals
Samuel N Rodgers-Melnick, PhD, MPH
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 50 to 80
Able to speak and understand English
Scheduled to undergo a surgery meeting the following criteria: (1) traditional open surgery (not laparoscopic or robotic) via laparotomy (midline or subcostal incisions), (2) length of surgery \>3 hours, and (3) curative-intent surgical resection of a cancer in the stomach, pancreas, bile ducts, liver, or peritoneal surfaces
Participant reports pain intensity of 4/10 or above to study staff on day 1 post-surgery or any other day post-surgery through discharge

Exclusion

Significant visual impairment that has not been corrected
Significant hearing impairment that has not been corrected
Significant cognitive impairment that would prevent participant from participating in the study
  • Proportion of participants whose phlebotomy was collected prior to surgeryWithin 2 weeks prior to surgery

    The feasibility of collecting blood samples prior to surgery is measured by the proportion of participants whose phlebotomy was successfully collected.

  • Proportion of participants whose phlebotomy was collected post-surgery (pre-MARI)Post-surgery and prior to MARI intervention (up to 30 days)

    The feasibility of collecting blood samples post-surgery (and pre-MARI intervention) is measured by the proportion of participants whose phlebotomy was successfully collected.

  • Proportion of participants whose phlebotomy was collected post-MARIPost-MARI intervention (up to 30 days)

    The feasibility of collecting blood samples post-MARI is measured by the proportion of participants whose phlebotomy was successfully collected.